Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2020-03-30 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司2019年度募集资金存放与使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Guojin Securities Co., Ltd. regarding the deposit and use of raised funds by Wuxi Xiangsheng Medical Technology Co., Ltd. for the fiscal year 2019. It includes specific financial figures about the amount raised, usage, balance, and management of the funds, as well as compliance with relevant regulations and agreements. The document references regulatory approvals, audit reports, and includes detailed tables on fund usage and investment projects. This type of document is a standalone audit or verification report focused on the use of raised capital, not a full annual report or interim financial report. It does not present comprehensive financial statements or management discussion but rather an audit opinion on a specific aspect (funds raised and their use). Therefore, it fits best under the category of Audit Report / Information (AR). The document length (5763 characters) and content confirm it is a full report, not just an announcement or certification letter, so it is not RPA or RNS. FY 2019
2020-03-30 Chinese
2019年度董事会审计委员会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2019 Annual Board Audit Committee Work Report" of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the audit committee's activities during 2019, including review of the 2018 financial audit, evaluation of external auditors, internal audit guidance, and internal control effectiveness. The content focuses on audit committee oversight and audit-related work rather than presenting full financial statements or comprehensive annual financial performance. The document length is 2257 characters, which is relatively short and consistent with a committee work report rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed committee report on audit activities. This fits best with the category of Audit Report / Information (AR), which includes standalone audit reports and audit committee work reports, excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2019
2020-03-30 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by Wuxi Xiangsheng Medical Technology Co., Ltd. It details the reasons for the change, the approval process by the board and supervisory committee, and the opinions of independent directors and the supervisory board. The document does not contain full financial statements or comprehensive financial data but rather informs about the policy change and its expected impact. It is a regulatory announcement related to accounting policy changes, not a full audit report or annual/interim report. Given the nature and length of the document (1629 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-30 Chinese
第一届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the first board of directors of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes approvals of various reports and proposals related to the 2019 annual report, financial statements, profit distribution, auditor appointment, and other governance matters. The document repeatedly states that these matters will be submitted to the 2019 annual general meeting for approval. It references the 2019 annual report and other related documents but does not contain the full annual report or detailed financial statements itself. The document length is 3331 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, this document is best classified as Board/Management Information (MANG), as it announces board meeting decisions and management resolutions rather than the full annual report or other filings.
2020-03-30 Chinese
独立董事关于2019年度对外担保情况的专项说明及独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding the company's external guarantees for the fiscal year 2019. It references regulatory notices from the China Securities Regulatory Commission about external guarantees and related party fund occupation. The document is very short (458 characters) and consists mainly of a formal statement and signatures by independent directors. It does not contain financial statements or detailed audit results, nor is it a full annual report or audit report. It is a regulatory compliance statement related to external guarantees, which fits best under Regulatory Filings (RNS) as it does not meet criteria for Audit Report (AR) or Annual Report (10-K).
2020-03-30 Chinese
容诚会计师事务所（特殊普通合伙）对公司控股股东及其关联方占用资金情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a detailed audit-related statement concerning non-operating fund occupation and other related party fund transactions for Wuxi Xiangsheng Medical Technology Co., Ltd. It references an audit report issued on March 29, 2020, for the fiscal year ending December 31, 2019, and includes a summary table of related party transactions. The document is issued by an accounting firm and includes audit partner certifications. It is not the full annual report but a standalone audit-related disclosure focusing on specific audit findings and compliance with regulatory requirements regarding related party transactions. The document length (8371 characters) and content indicate it is a specialized audit report or information related to audit findings rather than a full annual report or other types of filings. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2019
2020-03-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.